The Figali care center, in Amador, received on Wednesday the first 300 doses of the drug Molnupiravir (for oral use in the early management of covid -19 reports The Ministry of Health (Minsa)

"Today we start with oral treatment for patients who have risk factors such as obesity, hypertension, diabetes, who smoke, with lung diseases, who have problems with the central nervous system and who want to receive the medication," reported Yashica González, coordinator of the outpatient program at the Figali care center.

At the site in Amador, which was opened in August 2020 due to the pandemic, there are currently 30 patients with covid-19. Most are only for surveillance and a few receive oxygen support, González explained.

The distribution of the drug Molnupiravir began Monday in the 15 health regions of the country.

The medicine will be provided for those over 18 years of age, in the first 5 days of symptoms.

According to Health Minister, Luis Francisco Sucre, this drug will reduce hospitalizations and complications, while reducing the duration of symptoms.

Sucre also announced that paxlovid should arrive in the next few days, another drug that seeks to reduce the number of hospitalized patients and patients with complications.